Slide Left Slide Right

Geras Solution’s mission is to be a leading provider of Digital Healthcare solutions, via mobile app, for cognitive impairment diagnosis, support and disease management throughout the entire dementia cycle.

Our priority is to provide a clear pathway towards a reliable dementia specialist assessment that is time efficient and cost effective.

Learn more

Geras Solutions has the possibility to decrease the clinical assessment time by over 50% through its Pre-Diagnosis tool”
- Göran Hagman
Karolinska Hospital Memory Clinic



Pre Diagnosis

The Pre Diagnosis stage utilizes telemedicine to connect concerned users with dementia nurses and doctors to form a pre-diagnosis of the disease, utilizing amongst other standard tests and other gold-standard diagnostics used by the healthcare system. The Pre-Diagnosis gives an early indication of the disease to the user and creates a ‘database’ of test results to be used by the healthcare system during the formal diagnosis process, saving time and resources in the physical clinic.

Post Diagnosis

The Post Diagnosis features provides a practical toolkit for users diagnosed with dementia which help manage the disease and empower the user to take action to prevent further decay of mental health. Patients are able to consult with our certified dementia specialists and receive guidance relevant to disease management.

Contact us

Currently Geras is in the production phase of the first turnkey solution for the digital dementia space.

Geras app scientific note

The Geras Solutions app is based on scientifically validated methodologies for preventing and delaying the onset of dementia and equip the consumer and caregivers with knowledge based on the latest research outcomes.

The successful multidomain intervention developed in the FINGER study is the main inspiration for the app structure and content.The app allows users to proactively reduce their risk of developing dementia. They are able to use digital versions of gold-standard diagnostic tools in cognitive status screening and contact specialists in dementia treatment.

Users who already have a dementia diagnosis will have access to a practical toolkit to help them manage the disease and empower them to prevent further decay of cognitive functions.

Currently, trials are running in memory clinics with the purpose of clinically testing the app's tools prior to launch and scaling. Concurrent pilot studies will be run at several nursing homes internationally to further refine tools for caregivers.

Kivipelto M, Solomon A Ahtiluoto S, Ngandu T, LehtisaloJ, Antikainen R, Backman L. Hanninen T, Jula A Laatikainen T, Lindstrom J, Mangialasche F, Nissinen A Paajanen T, Pajala S. Peltonen M, Rauramaa R, Stigsdotter-Neely A,Strandberg T, TuomilehtoJ, Soininen H. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement. 2013 Nov;9(6):657-65. doi: 10.1016/jjalz.2012.09.012.
Ngandu T, Lehtisolo J, Solomon A Levalahti 6 Ahtiluoto 5, Antikainen R, Backman L, Hanninen T, Jula A Laatikainen T, Lindstrom J, Mangialosche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-NeelyA Strandberg T, TuomilehtoJ, Soininen H, Kivipelto M. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomized controlled trial. Lancet. 2015 Jun 6;385(9984):2255-63. doi: 10.1016/50140-6736(15)60461-5.


  • Haza Newman


  • Katarzyna Hess-Wiktor

    Content Development Manager

  • Andrea Andiloro

    Digital Media Coordinator

  • Björn Assedahl

    Motion Creative Designer




    • Göran Hägglund

      Former Minister of Health in Sweden (2006-2014)

      • Gustaf Bucht

        Professor Emeritus of Geriatric Medicine, Umeå University

        • Miia Kivipelto

          Professor of Geriatrics, Karolinska Institute





          • Bo Mattsson


            • Lars Ekström

              Board Member

              • Karin Lind-Mörnesten

                Board Member

              • Ludvig Mörnesten

                Board Member

              Contact us




              Karlavägen 86

              SE-115 22

              Stockholm, SWEDEN